OPN1SW and acute lymphoblastic leukemia: Provisionally on treatment Day 8, approximately a third of BCP-ALL patients were each categorised as SR (821/2466, 33%), IR (827/2466, 34%) and HR (818/2466, 33%) (Fig. 1).